NASDAQ: LBRX LB PHARMACEUTICALS INC 8-K

LB Pharmaceuticals reports Q4 and full-year 2025 financial results

Filed March 26, 2026 · Period ending March 26, 2026 · ~1 min read

Key Changes

  • medium

    Company announced fourth quarter and full-year 2025 earnings through press release dated March 26, 2026. Specific financial figures are contained in the attached exhibit not included in the 8-K body.

    Item 2.02 verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SMID 10-Q) is open in full — no account needed.

Partner

Trade LBRX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · Jun 11, 2026 4:07 AM